Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 24,833Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 8Orkambi

PharmaCompass

01

Brand Name : Orkambi

Lumacaftor

arrow
Antibody Engineering
Not Confirmed

Brand Name : Orkambi

arrow
Antibody Engineering
Not Confirmed

Lumacaftor

Main Therapeutic Indication : Respiratory Disorders

Currency : USD

2019 Revenue in Millions : 1,176

2018 Revenue in Millions : 1,262

Growth (%) : -7

blank

02

Brand Name : Orkambi

Lumacaftor

arrow
Antibody Engineering
Not Confirmed

Brand Name : Orkambi

arrow
Antibody Engineering
Not Confirmed

Lumacaftor

Main Therapeutic Indication : Respiratory Disorders

Currency : USD

2020 Revenue in Millions : 908

2019 Revenue in Millions : 1,176

Growth (%) : -23

blank

03

Brand Name : Orkambi

Lumacaftor

arrow
Antibody Engineering
Not Confirmed

Brand Name : Orkambi

arrow
Antibody Engineering
Not Confirmed

Lumacaftor

Main Therapeutic Indication : Respiratory Disorders

Currency : USD

2021 Revenue in Millions : 772

2020 Revenue in Millions : 908

Growth (%) : -18

blank

04

Brand Name : Orkambi

Lumacaftor

arrow
Antibody Engineering
Not Confirmed

Brand Name : Orkambi

arrow
Antibody Engineering
Not Confirmed

Lumacaftor

Main Therapeutic Indication : Genetic Diseases

Currency : USD

2022 Revenue in Millions : 511

2021 Revenue in Millions : 772

Growth (%) : -34

blank

05

Brand Name : Orkambi

Lumacaftor

arrow
Antibody Engineering
Not Confirmed

Brand Name : Orkambi

arrow
Antibody Engineering
Not Confirmed

Lumacaftor

Main Therapeutic Indication : Genetic Diseases

Currency : USD

2023 Revenue in Millions : 326

2022 Revenue in Millions : 511

Growth (%) : -57

blank

06

Brand Name : Orkambi

Lumacaftor/ Ivacaftor

arrow
Antibody Engineering
Not Confirmed

Brand Name : Orkambi

arrow
Antibody Engineering
Not Confirmed

Lumacaftor/ Ivacaftor

Main Therapeutic Indication : Respiratory Disorders

Currency : USD

2016 Revenue in Millions : 980

2015 Revenue in Millions : 351

Growth (%) : 179

blank

07

Brand Name : Orkambi

Lumacaftor/Ivacaftor

arrow
Antibody Engineering
Not Confirmed

Brand Name : Orkambi

arrow
Antibody Engineering
Not Confirmed

Lumacaftor/Ivacaftor

Main Therapeutic Indication : Respiratory Disorders

Currency : USD

2017 Revenue in Millions : 1,321

2016 Revenue in Millions : 980

Growth (%) : 35

blank

08

Brand Name : Orkambi

Lumacaftor/Ivacaftor

arrow
Antibody Engineering
Not Confirmed

Brand Name : Orkambi

arrow
Antibody Engineering
Not Confirmed

Lumacaftor/Ivacaftor

Main Therapeutic Indication : Respiratory Disorders

Currency : USD

2018 Revenue in Millions : 1,262

2017 Revenue in Millions : 1,321

Growth (%) : -4%

blank